Vincera Pharma Inc (VINC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Operating Expenses | 3,334 | 8,826 | 7,793 | 7,366 | 7,478 |
| Operating Income | -3,334 | -8,826 | -7,793 | -7,366 | -7,478 |
| Other Income | -1,666 | 832 | -50 | 5,558 | -4,951 |
| Pre-tax Income | -5,000 | -7,994 | -7,843 | -1,808 | -12,429 |
| Net Income Continuous | -5,000 | -7,994 | -7,843 | -1,808 | -12,429 |
| Net Income | $-5,000 | $-7,994 | $-7,843 | $-1,808 | $-12,429 |
| EPS Basic Total Ops | -1.40 | 0.01 | -3.40 | -1.00 | -11.46 |
| EPS Basic Continuous Ops | -1.40 | -0.01 | -3.43 | -0.94 | -11.46 |
| EPS Diluted Total Ops | -1.40 | 0.01 | -3.40 | -1.00 | -11.46 |
| EPS Diluted Continuous Ops | -1.40 | -0.01 | -3.43 | -0.94 | -11.46 |
| EPS Diluted Before Non-Recurring Items | -0.91 | N/A | -3.40 | -1.00 | -6.80 |
| EBITDA(a) | $-3,334 | $-8,578 | $-7,696 | $-7,096 | $-7,214 |